Passage Bio, Inc. (PASG) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts PASG Hot Sheet
Join SI Premium – FREE
Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.73), $0.09 better than the analyst estimate of ($0.82).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble
- Hertz cuts guidance, announces notes and stock offerings, shares sink
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
